By Ryan Davis ( February 12, 2010, 4:16 PM EST) -- An Indian court has reportedly denied an appeal by Bayer AG that sought to block the sale of a generic version of its cancer drug Nexavar, the latest in a series of setbacks for branded-drug companies involved in patent disputes in the country....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.